Fractyl Health Expands Landmark Academic-Industry Collaboration to Study Mechanisms Underlying GLP-1-Based Pancreatic Gene Therapy for Type 2 Diabetes and Obesity
November 16, 2023 08:28 ET
|
Fractyl Health, Inc.
FRACTYL HEALTH EXPANDS LANDMARK ACADEMIC-INDUSTRY COLLABORATION TO STUDY MECHANISMS UNDERLYING GLP-1-BASED PANCREATIC GENE THERAPY FOR TYPE 2 DIABETES AND